Fig. 3From: Safety and efficacy of temsirolimus as second line treatment for patients with recurrent bladder cancerSwimmer plot indicating the number of patients treated with temsirolimus as a function of treatment duration. Red diamonds: PR; blue diamonds: SD; black diamonds: progression or deathBack to article page